Gold Prices Drop After Trump Signals Warsh as Fed Pick

Gold Prices Drop after Trump signals Kevin Warsh as Fed chair, strengthening the U.S. dollar and forcing traders to rebalance amid a steep metals sell-off.

January 30, 2026·2 min read
View all news articles
Bank vault with a dimming gold bar symbolizing Gold Prices Drop after a Fed chair pick and metals sell-off.

KEY TAKEAWAYS

  • Gold fell about 10.0% to $5,136 per ounce after the Warsh pick.
  • Silver prices plunged, marking the worst day for precious metals since the 1980s.
  • A firmer U.S. dollar and profit-taking amplified the metals sell-off and shifted trader positioning.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Gold prices dropped sharply on Jan. 30, 2026, after President Donald Trump announced his intention to nominate Kevin Warsh as Federal Reserve chair. The move intensified expectations of tighter monetary policy, strengthened the U.S. dollar, and triggered a steep sell-off in precious metals.

Gold and Silver Plunge

Gold fell about 10%, sliding from $5,500 per ounce to $5,136 in an intraday sell-off following the Fed chair announcement. Silver prices also plunged, marking the worst day for precious metals since the 1980s. The decline came after metals had reached record highs earlier in the year and reflected profit-taking amid a firmer U.S. dollar, which amplified the losses.

Warsh Nomination and Policy Outlook

President Trump said he plans to nominate Kevin Warsh to replace Jerome Powell as Fed chair. Warsh served on the Federal Reserve Board from 2006 to 2011 and was involved in the central bank’s response to the 2008 financial crisis. He later criticized large Fed asset purchases and the handling of inflation.

Warsh is viewed as hawkish, generally supporting higher interest rates and critical of the Fed’s balance-sheet size. He has indicated openness to lowering short-term rates only if the balance sheet is substantially reduced. His affiliations include the Hoover Institution, the family office of Stanley Druckenmiller, and board roles at UPS and Coupang.

Since September 2025, the Fed has cut its policy rate by 0.75 percentage point, with markets pricing in one more cut this year. Inflation remains above the Fed’s 2% target, and policymakers have signaled caution amid tariffs and a tight labor market.

The nomination requires U.S. Senate confirmation and faces potential political hurdles linked to GOP criticism over Department of Justice subpoenas involving Powell. Powell’s term as Fed chair ends in May 2026, though he could remain on the Fed Board through 2028, making the confirmation process a key factor in the central bank’s leadership and near-term policy direction.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Deckers Q3 2026 Earnings Show HOKA Momentum

Deckers Q3 2026 Earnings Show HOKA Momentum

Deckers Q3 2026 earnings beat estimates and management raised FY2026 guidance as HOKA growth and pricing offset tariff pressure, supporting larger buybacks

Palantir Earnings Test AI Momentum Ahead of Feb. 2

Palantir Earnings Test AI Momentum Ahead of Feb. 2

Palantir earnings test enterprise-AI momentum after rapid commercial growth and raised guidance, while ICE ties and sector weakness pressure the stock.

SpaceX Tesla Merger Boosts Tesla Stock

SpaceX Tesla Merger Boosts Tesla Stock

SpaceX Tesla merger talks lifted Tesla shares on Jan. 30 as SpaceX weighs a tie-up with Tesla or xAI ahead of a mid-2026 IPO, creating a trading window.

Charter Q4 2025 Results: Revenue Slip, Mobile Gains

Charter Q4 2025 Results: Revenue Slip, Mobile Gains

Charter Q4 2025 results showed revenue fell on weaker video and political ads, but mobile growth and stronger free cash flow limited downside for shares.

Kevin Warsh Fed Chair Nomination

Kevin Warsh Fed Chair Nomination

Kevin Warsh Fed Chair Nomination raises odds of faster balance-sheet reduction and bank deregulation, heightening policy uncertainty and trader volatility.

Eli Lilly Pennsylvania Plant to Boost Capacity

Eli Lilly Pennsylvania Plant to Boost Capacity

Eli Lilly Pennsylvania plant adds U.S. drugmaking capacity and embodies a $3.5 billion capital push that keeps investor focus on factory build-out.